EyePoint (EYPT) Profit After Tax (2010 - 2026)
EyePoint (EYPT) reported Profit After Tax of -$84.8 million for Q1 2026, down 87.27% on a YoY basis from -$666.2 million in Q1 2025, and down 25.47% sequentially from -$67.6 million in Q4 2025.
EyePoint (EYPT) Profit After Tax (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 17 years of Profit After Tax data on file, last reported at -$84.8 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 87.27% year-over-year to -$84.8 million; the trailing twelve-month figure through Mar 2026 stood at -$271.6 million (down 85.0% YoY), and the FY2025 full-year result was -$232.0 million, down 77.25% from the prior year.
- Profit After Tax retreated to -$84.8 million in Q1 2026, from -$67.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$12.6 million in Q3 2023 to a low of -$84.8 million in Q1 2026.
- A 5-year average of -$36.5 million and a median of -$29.3 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax soared 67.65% in 2023 and sank 196.29% in 2024, its largest moves.
- Tracing EYPT's Profit After Tax over 5 years: stood at -$43.5 million in 2022, then soared by 67.65% to -$14.1 million in 2023, then slumped by 196.29% to -$41.7 million in 2024, then sank by 62.11% to -$67.6 million in 2025, then dropped by 25.47% to -$84.8 million in 2026.
- Business Quant data shows EYPT's Profit After Tax at -$84.8 million in Q1 2026, -$67.6 million in Q4 2025, and -$59.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -84.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.83 Mn |
| Dec 31, 2025 | -67.61 Mn |
| Sep 30, 2025 | -59.73 Mn |
| Jun 30, 2025 | -59.43 Mn |
| Mar 31, 2025 | -45.30 Mn |
| Dec 31, 2024 | -41.71 Mn |
| Sep 30, 2024 | -28.98 Mn |
| Jun 30, 2024 | -30.83 Mn |
| Mar 31, 2024 | -29.28 Mn |
| Dec 31, 2023 | -14.08 Mn |
| Sep 30, 2023 | -12.61 Mn |
| Jun 30, 2023 | -22.92 Mn |
| Mar 31, 2023 | -21.16 Mn |
| Dec 31, 2022 | -43.51 Mn |
| Sep 30, 2022 | -18.42 Mn |
| Jun 30, 2022 | -19.59 Mn |
| Mar 31, 2022 | -20.98 Mn |
| Dec 31, 2021 | -19.43 Mn |
| Sep 30, 2021 | -16.70 Mn |
| Jun 30, 2021 | -10.01 Mn |